FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Peginterferon alfa-2a 180micrograms/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Everolimus 2.5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1500mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 500mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1g/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 360mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ofatumumab 1g/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 100mg/4ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 27.5mg/1.1ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 40mg/20ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/5ml oral solution sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 320mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 10.72mg implant pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12.5mg/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 17.5mg/0.35ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ceritinib 150mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 50mg/50ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axitinib 5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 25mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon gamma-1b (recombinant human) 100micrograms/0.5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 200mg/8ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 15mg/1.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trametinib 500micrograms tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 75mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 630mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacarbazine 100mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinorelbine 30mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b 1million units/ml eye drops preservative free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2a (rbe) 6million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2a (rbe) 3million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1.2g/48ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 20mg/0.72ml solution for infusion vials and diluent Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b (rbe) 80microgram powder and solvent for solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Rucaparib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cladribine 10mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 750micrograms/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/0.15ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinorelbine 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Chlormethine 160micrograms/g gel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacarbazine 1g powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine 10mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3950mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alemtuzumab 12mg/1.2ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2000mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cladribine 10mg/5ml solution for injection vials Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b 150microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Anagrelide 500microgram capsules Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aflibercept 4mg/100microlitres solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 900mg/36ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitoxantrone 20mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 6mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemtuzumab 5mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2a (rbe) 18million units/0.6ml solution for injection cartridges Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 6400mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3500mg/120ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tasonermin 1mg powder and solvent for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 500mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b 10million units/1ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2250mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nintedanib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 12million units/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1800mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 160mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 22.5mg/0.45ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1.8g/180ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Thiotepa 15mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b 25million units/2.5ml solution for injection multidose vials Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 80mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 22.5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 200mg/10ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 500mg/25ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 85mg/3.4ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1400mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fludarabine phosphate 50mg/2ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alitretinoin 30mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinorelbine 50mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2250mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon beta-1a 63micrograms/0.5ml solution for injection pre-filled disposable devices and Peginterferon beta-1a 94micrograms/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ingenol mebutate 150micrograms/g gel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitoxantrone 10mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 80mg/4ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 5mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 40mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temsirolimus 30mg/1.2ml solution for infusion vials and diluent Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carfilzomib 10mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 2g/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alemtuzumab 30mg/3ml solution for injection ampoules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1b 300microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cytarabine 1g/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 0.02% eye drops preservative free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3950mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 18 of 26 Next End

This concept is not in any reference sets

Back to Start